Pacific Biosciences Of California (PACB) Interest & Investment Income (2012 - 2013)

Pacific Biosciences Of California's (PACB) quarterly Interest & Investment Income came in at -$19000.0 in Q1 2013, down 124.36% year-on-year from $78000.0 in Q1 2012, and down 124.36% quarter-over-quarter from $78000.0 in Q1 2012.

Pacific Biosciences Of California (PACB) Interest & Investment Income (2012 - 2013) Analysis & Trends

Pacific Biosciences Of California's Interest & Investment Income history runs 2 years deep, the most recent figure standing at -$19000.0 for Q1 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 106.00 Mn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 33.50 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 40.98 Mn
10 Pacific Biosciences Of California 415.91 Mn 139.95 Mn 12.84 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2013 -19,000.00
Mar 31, 2012 78,000.00